The cost-effectiveness of fluconazole prophylaxis against primary systemic fungal infections in AIDS patients.
about
Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIVCost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South AfricaCost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in CambodiaPathogenesis and prevention of immune reconstitution disease during antiretroviral therapy.Pharmacoeconomics of antifungal pharmacotherapy--challenges and future directions.Cost-effectiveness of HIV testing and treatment in the United StatesA systematic review of cost-utility analyses in HIV/AIDS: implications for public policy.A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand.Prevention of human immunodeficiency virus-related opportunistic infections in France: a cost-effectiveness analysis.A meta-analysis of utility estimates for HIV/AIDS.Preevaluation of clinical trial data: the case of preemptive cytomegalovirus therapy in patients with human immunodeficiency virus
P2860
Q24246431-9CDDDF90-AB66-4D53-8D83-1ED41E4F9EB2Q28534733-7F0A6617-CBB9-4CFA-823C-76D1124EA0BDQ28748511-E96D4C6C-411D-4160-A498-49103852CDBAQ35656939-4A1CB82F-3298-45E4-BE39-4EB25114E144Q36326220-9DE2ADBC-D89B-44E1-9DF0-EC7B332A6C03Q36628399-432E34EE-936D-4A64-8155-01F094BC92F9Q37023469-2F4CD557-2F7A-4EF9-B941-B9A90F8E64A5Q43820687-C3714592-0106-4540-B44A-9C50629E65DAQ44255331-8F3E2D9F-5CE6-4187-87C7-6958C1232A70Q46061609-4A5F4CAE-CFB0-4DE4-BEF6-96705FD2B417Q56898222-A5F52EA9-391E-4632-B667-E6D759E1ED7C
P2860
The cost-effectiveness of fluconazole prophylaxis against primary systemic fungal infections in AIDS patients.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
The cost-effectiveness of fluc ...... l infections in AIDS patients.
@en
The cost-effectiveness of fluc ...... l infections in AIDS patients.
@nl
type
label
The cost-effectiveness of fluc ...... l infections in AIDS patients.
@en
The cost-effectiveness of fluc ...... l infections in AIDS patients.
@nl
prefLabel
The cost-effectiveness of fluc ...... l infections in AIDS patients.
@en
The cost-effectiveness of fluc ...... l infections in AIDS patients.
@nl
P2093
P2860
P1476
The cost-effectiveness of fluc ...... l infections in AIDS patients.
@en
P2093
A D Paltiel
J A Scharfstein
K A Freedberg
P2860
P304
P356
10.1177/0272989X9701700402
P577
1997-10-01T00:00:00Z